Pemphigoid Gestationis Refractive to Dual Systemic Therapy Treated With Dupilumab

Key Points

• Dupilumab treatment led to significant improvement in symptoms of pemphigoid gestationis, indicating its effectiveness.
• The case demonstrates a favorable outcome after dual systemic therapy had proven ineffective for the patient.
• Assessment involved individual patient history and clinical observations over the course of treatment.
• Dupilumab's role signals a shift in treatment strategies, requiring further exploration in broader populations.

Abstract